HIGHLIGHTS
- who: ufeffZeluufeff ufeffDuufeff from the Fourth Military Medical University, China have published the research work: Potential novel therapeutic strategies for neuropathic pain, in the Journal: (JOURNAL) of December/08,/2022
- what: The current trial provides strong evidence for the effectiveness of these two methods on SC. The current trial aims at testing the effect of low ETX doses on NP patients, which can further strengthen the clinical application of LVA calcium channel blockers.
- future: Since no drugs targeting NMDAR have been applied clinically and NMDAR plays an important role in NP NYX-2925 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.